Skip to main content

Table 2 Mendelian randomization (MR) results where glucose, HbA1c and T2DM as the outcome and IBD as the exposure

From: No causal relationship between glucose and inflammatory bowel disease: a bidirectional two-sample mendelian randomization study

Outcome

P

OR(95%CI)

P for Q-Test

P for Intercept

Fasting glucose

    

IVW

0.590

0.995(0.977–1.013)

2.27*10− 6

0.868

MR Egger

0.958

0.999(0.953–1.046)

  

Simple mode

0.628

0.994(0.972–1.016)

  

Weighted median

0.393

0.994(0.981–1.007)

  

Weighted mode

0.419

0.993(0.977–1.009)

  

HbA1c

    

IVW

0.203

1.052(0.973–1.137)

5.96*10− 3

0.442

MR Egger

0.248

1.132(0.931–1.376)

  

Simple mode

0.580

0.973(0.884–1.069)

  

Weighted median

0.592

1.019(0.950–1.093)

  

Weighted mode

0.887

1.006(0.932–1.084)

  

T2DM

    

IVW

0.964

0.998(0.917–1.085)

6.20*10− 3

0.837

MR Egger

0.851

1.035(0.733–1.461)

  

Simple mode

0.793

1.014(0.920–1.115)

  

Weighted median

0.688

1.014(0.948–1.082)

  

Weighted mode

0.664

1.019(0.940–1.103)

  
  1. MR: Mendelian Randomization; IBD: Inflammatory Bowel Disease; T2DM: type 2 diabetes; IVW: inverse variance weighted; OR: odds ratio; CI: confidence interval